Home
Carlos Alcaraz’s quest for glory at the Madrid Masters hangs in the balance after a troubling injury disrupted his Barcelona Open final clash with Holger Rune. The Spanish sensation, fresh off a triumphant run at the Monte Carlo Masters, now faces an anxious wait for medical results that could derail his clay-court campaign. With a pivotal scan set to determine his fitness, Alcaraz’s hopes of reclaiming the world No. 2 ranking—and solidifying his Roland Garros preparations—are clouded by uncertainty.
Carlos Alcaraz’s psoas struggle threatens season momentum
Alcaraz’s Barcelona final began with promise, as he broke Rune early, showcasing the explosive tennis that has defined his rise. But momentum shifted when discomfort in his right psoas muscle—a critical core muscle linking the spine to the hips—left him visibly compromised.
Rune capitalized, snapping a 13-match losing streak against top-five foes to claim his maiden ATP 500 title. “It means the world,” the Dane reflected, acknowledging Alcaraz’s early dominance.
For Alcaraz, the physical toll of back-to-back tournaments now poses a stark challenge. The psoas, essential for hip flexibility and spinal stability, governs the rotational power behind his thunderous forehands and agile court coverage.
“When you feel pain there, alarm bells ring,” admitted the 20-year-old, who struggled to maintain intensity after the first set.
His post-match revelation of “discomfort” and plans for a two-day recovery window underscore the delicate balance between ambition and preservation.
The stakes couldn’t be higher. Alexander Zverev’s Munich victory on his 28th birthday will bump Carlos Alcaraz to No. 3 in the rankings—a psychological blow as the Madrid Masters looms. A favorable scan could allow Alcaraz to request a delayed start in Madrid, where he’s slated for a first-round bye. However, his admission of fatigue—"two weeks of nonstop play"—hints at a deeper need for rest, even if the scan clears him.
The road ahead: Recovery vs. relentless schedule
Alcaraz’s predicament highlights the grueling demands of the ATP calendar. With the French Open approaching, pushing through injury risks long-term consequences. Yet skipping Madrid, a home-soil event where he’s a crowd favorite, would dent his momentum and cede ground to rivals like Zverev and Jannik Sinner.
As the tennis world awaits the scan’s verdict, Carlos Alcaraz’s team faces a dilemma: prioritize immediate success or safeguard his future. For a player whose game thrives on physicality, the psoas issue isn’t just a hiccup—it’s a test of resilience.
ADVERTISEMENT
